Daphne S Bakker

16PUBLICATIONS
35CO-AUTHORS
Gene and molecular therapyAllergyMolecular targetsDental therapeutics, pharmacology and toxicologyPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 24, 2025
Biologics to Treat Atopic Dermatitis: Effectiveness, Safety, and Future Directions.

Marjolein S de Bruin-Weller, Celeste M Boesjes, Roselie A Achten

|Dec 14, 2024
Tralokinumab Treatment in Adult Atopic Dermatitis Patients: 28-Week Evaluation of Clinical Effectiveness, Safety, Serum Proteins and Total IgE Levels.

Coco Dekkers, Nicolaas Zuithoff, Daphne Bakker

|Feb 09, 2024
Ocular surface disease in moderate-to-severe atopic dermatitis patients and the effect of biological therapy.

Roselie Achten, Judith Thijs, Marlot van der Wal

|Mar 19, 2023
Dupilumab-associated ocular surface disease in atopic dermatitis patients: Clinical characteristics, ophthalmic treatment response and conjunctival goblet cell analysis.

Roselie Achten, Judith Thijs, Marlot van der Wal

|Dec 24, 2022
Dupilumab in daily practice for the treatment of pediatric atopic dermatitis: 28-week clinical and biomarker results from the BioDay registry.

Esmé Kamphuis, Celeste M Boesjes, Laura Loman

|Jul 15, 2022
Patient-centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis.

Lotte S Spekhorst, Daphne Bakker, Julia Drylewicz

Pageof 3

Frequent Collaborators

12 joint publications

Marjolein S de Bruin-Weller

8 joint publications

Judith Thijs

6 joint publications

Celeste M Boesjes

5 joint publications

Roselie E Achten